IL1B and Insulin resistance: While MEFV mutations and inflammatory cytokines such as IL-1β may create a proinflammatory environment that promotes insulin resistance, additional factors such as adipose tissue dysfunction and hyperuricemia likely contribute to metabolic deterioration.